Compound profile

Sermorelin

Also known as GHRH (1-29), Geref

Previously approved
  • Growth hormone secretagogues

Last reviewed October 2026

Educational only. A summary of published research, not medical advice or a recommendation. No doses are listed.

Quick take

A shortened form of growth hormone–releasing hormone made of its first 29 amino acids.

Class
Growth hormone secretagogues
Status
Previously approved
Evidence
Early or small human studies
Half-life
Not well documented

Mechanism fingerprint

What it acts on, and how. Each chip links to that pathway on the map.

Stimulates the pituitary to release growth hormone in natural pulses.

What makes it different

The first 29 amino acids of natural GHRH; it prompts growth hormone release in natural pulses and was once approved for children.

Compare side by side

Mechanism & pathways

Sermorelin
  • Agonist GHRH receptor in the pituitary

    Receptor in the pituitary gland for growth hormone–releasing hormone (GHRH). Activating it releases the body's own growth hormone in pulses.

    Leads to Growth hormone & GH receptor IGF-1

See Sermorelin on the pathway map

Evidence overview

Early or small human studies

Older clinical studies, mainly in children with growth hormone deficiency.

A breakdown into human, animal and cell studies hasn't been added for this compound yet.

Why it's used

Was used to test and treat growth hormone deficiency in children; now used off-label at some clinics to raise growth hormone.

Side effects & risks

Reported side effects

  • Injection-site reactions
  • Flushing
  • Headache

Risks and warnings

  • No longer available as an approved product in the US
  • Products sold as “research use only” are not quality-controlled medicines; purity, sterility and labeled amount are not verified.

FAQ

Short answers taken from this profile.

What is Sermorelin?

A shortened form of growth hormone–releasing hormone made of its first 29 amino acids.

How does Sermorelin work?

Stimulates the pituitary to release growth hormone in natural pulses.

What receptors or pathways does Sermorelin act on?

GHRH receptor (agonist; in the pituitary). Downstream, that leads to growth hormone & GH receptor and IGF-1.

How is Sermorelin different from similar compounds?

The first 29 amino acids of natural GHRH; it prompts growth hormone release in natural pulses and was once approved for children.

Is Sermorelin approved?

Was FDA-approved (Geref) for growth hormone deficiency in children; the brand was discontinued in the US in 2008.

What has Sermorelin been studied for?

Was used to test and treat growth hormone deficiency in children; now used off-label at some clinics to raise growth hormone.

How strong is the evidence?

Early or small human studies. Older clinical studies, mainly in children with growth hormone deficiency.

What are the main risks?

No longer available as an approved product in the US. Products sold as “research use only” are not quality-controlled medicines; purity, sterility and labeled amount are not verified.

Sources

  • Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs 1999.